EDGAR Verified
Primary Source · SEC.gov

INDIA LIFE SCIENCES FUND IV DOMESTIC

CIK 0002018126Fund Vehicle2025 vintage506(b), 3(c)(1)

Raised

$2M

Investors

3

Min Invest

$0

AltStreet Analysis

·

Generated from EDGAR primary sources

INDIA LIFE SCIENCES FUND IV DOMESTIC is a pooled investment fund operating under Rule 506(b) and 3(c)(1) exemptions. This amended filing reports $1.6M raised from 3 investors. The fund is incorporated in India and managed by executive officers Shweta Agrawal, Jeevak Gupta, and Anil Jagirdar.

This India-domiciled life sciences fund follows a standard 506(b)/3(c)(1) private fund structure typical of institutional alternative investments. The filing does not disclose minimum investment thresholds or first sale date, consistent with platform conventions for institutional fund vehicles that maintain detailed terms in private placement memoranda.

Data Flags

State of IncorporationEntity is incorporated in India but filing U.S. Form D, indicating cross-border investment structure with U.S. investor solicitation
First Sale DateAmendment filing with no first sale date disclosed despite modest raise of $1.6M; typically funds of this size include sale dates

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0002018126
Entity NameINDIA LIFE SCIENCES FUND IV DOMESTIC
Exemption506(b), 3(c)(1)
First Sale Date
Filing DateApril 22, 2025
Accession Number0002018126-25-000001
Total Amount Sold$2M
Total Investors3
Minimum Investment$0 (no stated minimum)
Securities TypeEquity, Pooled Investment Fund
State of IncorporationNot specified
Amendment CountOriginal filing only

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

Shweta Agrawal

Executive Officer · Hyderabad, Telangana, K7

Jeevak Gupta

Executive Officer · Hyderabad, Telangana, K7

Anil Jagirdar

Executive Officer · Hyderabad, Telangana, K7

Is this your offering?

Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.